Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam P Dicker

Showing results (161-170 of 286) with videos related to

Pageof 29
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2010
Decreasing the adverse effects of cancer therapy: National Cancer Institute guidance for the clinical development of radiation injury mitigatorsBenjamin Movsas, Bhadrasain Vikram, Martin Hauer-Jensen, et al.
International Journal of Radiation Oncology, Biology, Physics|September 30, 2016
Stereotactic Body Radiation Therapy Delivery in a Genetically Engineered Mouse Model of Lung CancerShisuo Du, Virginia Lockamy, Lin Zhou, et al.
American Journal of Clinical Oncology|August 16, 2012
Patterns of care for elderly men diagnosed with favorable-risk prostate cancer from 2004 to 2008: a population-based analysisMark V Mishra, Xinglei Shen, Robert B Den, et al.
Molecular Pharmaceutics|April 5, 2018
Improvement in Therapeutic Efficacy and Reduction in Cellular Toxicity: Introduction of a Novel Anti-PSMA-Conjugated Hybrid Antiandrogen NanoparticleChellappagounder Thangavel, Maryna Perepelyuk, Ettickan Boopathi, et al.
International Journal of Radiation Oncology, Biology, Physics|January 17, 2012
Phase I trial using the proteasome inhibitor bortezomib and concurrent chemoradiotherapy for head-and-neck malignanciesGregory J Kubicek, Rita S Axelrod, Mitchell Machtay, et al.
Oncotarget|July 21, 2016
β1 integrin- and JNK-dependent tumor growth upon hypofractionated radiationAejaz Sayeed, Huimin Lu, Qin Liu, et al.
Cancer|June 8, 2011
A phase 1b trial of the combination of the antiangiogenic agent sunitinib and radiation therapy for patients with primary and metastatic central nervous system malignanciesEvan J Wuthrick, Mitchell Kamrava, Walter J Curran, et al.
Urology|August 4, 2012
Prognostic factors and outcomes after definitive treatment of female urethral cancer: a population-based analysisColin E Champ, Sarah E Hegarty, Xinglei Shen, et al.
Journal of Hematology & Oncology|September 25, 2016
Immune biomarkers of treatment failure for a patient on a phase I clinical trial of pembrolizumab plus radiotherapyGregory S Alexander, Joshua D Palmer, Madalina Tuluc, et al.
Future Oncology (London, England)|November 25, 2011
Postprostatectomy radiation therapy: an evidence-based reviewMark V Mishra, Colin E Champ, Robert B Den, et al.
Pageof 29

Showing results (161-170 of 286) with videos related to

Sort By:
Pageof 29
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2010
Decreasing the adverse effects of cancer therapy: National Cancer Institute guidance for the clinical development of radiation injury mitigatorsBenjamin Movsas, Bhadrasain Vikram, Martin Hauer-Jensen, et al.
International Journal of Radiation Oncology, Biology, Physics|September 30, 2016
Stereotactic Body Radiation Therapy Delivery in a Genetically Engineered Mouse Model of Lung CancerShisuo Du, Virginia Lockamy, Lin Zhou, et al.
American Journal of Clinical Oncology|August 16, 2012
Patterns of care for elderly men diagnosed with favorable-risk prostate cancer from 2004 to 2008: a population-based analysisMark V Mishra, Xinglei Shen, Robert B Den, et al.
Molecular Pharmaceutics|April 5, 2018
Improvement in Therapeutic Efficacy and Reduction in Cellular Toxicity: Introduction of a Novel Anti-PSMA-Conjugated Hybrid Antiandrogen NanoparticleChellappagounder Thangavel, Maryna Perepelyuk, Ettickan Boopathi, et al.
International Journal of Radiation Oncology, Biology, Physics|January 17, 2012
Phase I trial using the proteasome inhibitor bortezomib and concurrent chemoradiotherapy for head-and-neck malignanciesGregory J Kubicek, Rita S Axelrod, Mitchell Machtay, et al.
Oncotarget|July 21, 2016
β1 integrin- and JNK-dependent tumor growth upon hypofractionated radiationAejaz Sayeed, Huimin Lu, Qin Liu, et al.
Cancer|June 8, 2011
A phase 1b trial of the combination of the antiangiogenic agent sunitinib and radiation therapy for patients with primary and metastatic central nervous system malignanciesEvan J Wuthrick, Mitchell Kamrava, Walter J Curran, et al.
Urology|August 4, 2012
Prognostic factors and outcomes after definitive treatment of female urethral cancer: a population-based analysisColin E Champ, Sarah E Hegarty, Xinglei Shen, et al.
Journal of Hematology & Oncology|September 25, 2016
Immune biomarkers of treatment failure for a patient on a phase I clinical trial of pembrolizumab plus radiotherapyGregory S Alexander, Joshua D Palmer, Madalina Tuluc, et al.
Future Oncology (London, England)|November 25, 2011
Postprostatectomy radiation therapy: an evidence-based reviewMark V Mishra, Colin E Champ, Robert B Den, et al.
Pageof 29